Clonal hematopoiesis risk tool predicts possibility of blood cancer

Clonal hematopoiesis risk tool predicts possibility of blood cancer

Credit: jarun011/Getty Images A new clinical tool, based on genetic mutations, blood cell parameters and age, can identify patients with clonal hematopoiesis (CH) who are most at risk of developing a myeloid malignancy. Details of the Clonal Hematopoiesis Risk Score (CHRS), developed by a team of researchers led by the Dana-Farber Cancer Institute, were presented …

Clonal hematopoiesis risk tool predicts possibility of blood cancer Read More »